Alexza Pharmaceuticals Inc (ALXA) financial statements (2023 and earlier)

Company profile

Business Address 2091 STIERLIN COURT
MOUNTAIN VIEW, CA 94043
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7,75534,77425,88422,800
Cash and cash equivalents7,75515,20017,30617,715
Short-term investments 19,5748,578 
Other undisclosed cash, cash equivalents, and short-term investments   5,085
Restricted cash and investments   5,051
Receivables 173129 
Inventory, net of allowances, customer advances and progress billings 3,7293,447
Inventory 3,7293,447 
Advances on inventory purchases1,024   
Prepaid expense and other current assets852
Other undisclosed current assets2,2133,1091,453(5,085)
Total current assets:10,99241,78530,91323,618
Noncurrent Assets
Property, plant and equipment3,32013,95314,99116,531
Restricted cash and investments 2,757  
Other noncurrent assets4193,0651,168
Prepaid expense and other noncurrent assets402
Total noncurrent assets:3,73919,77516,15916,933
TOTAL ASSETS:14,73161,56047,07240,551
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,43210,4177,2244,313
Accounts payable4421,7993,7892,147
Accrued liabilities6,9905,837  
Employee-related liabilities 2,7813,4352,166
Debt46,84063,76711,5246,461
Business combination, contingent consideration, liability9001,700
Deferred revenue and credits2,8482,4502,9152,915
Other undisclosed current liabilities178(66,817)(6,765)5,029
Total current liabilities:58,19811,51714,89818,718
Noncurrent Liabilities
Long-term debt and lease obligation21,12763,76710,744 
Long-term debt, excluding current maturities21,12763,767  
Capital lease obligations  10,744 
Liabilities, other than long-term debt7,06437,9298,59013,160
Deferred revenue and credits3,4127,8448,59013,160
Other liabilities1,752985  
Business combination, contingent consideration, liability1,90029,100
Total noncurrent liabilities:28,191101,69619,33413,160
Total liabilities:86,389113,21334,23231,878
Stockholders' equity
Stockholders' equity attributable to parent(71,658)(51,653)(23,975)2,573
Common stock2222
Additional paid in capital360,610359,308350,250337,184
Accumulated other comprehensive income (loss) (3)1 
Accumulated deficit(432,270)(410,960)(374,228)(334,613)
Total stockholders' equity:(71,658)(51,653)(23,975)2,573
Other undisclosed liabilities and equity  36,8156,100
TOTAL LIABILITIES AND EQUITY:14,73161,56047,07240,551

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues5,0265,56147,8394,070
Revenue, net2,6712,99747,8394,070
Cost of revenue(21,129)(15,925)(11,224)(415)
Cost of goods and services sold(21,129)(15,925)(11,209) 
Gross profit:(16,103)(10,364)36,6153,655
Operating expenses(23,921)(27,100)(34,845)(32,527)
Other undisclosed operating income 8  
Operating income (loss):(40,024)(37,456)1,770(28,872)
Nonoperating income
(Debt Instrument, Convertible, Beneficial Conversion Feature)
 1,0323,112 
Interest and debt expense(8,446)(7,438)(1,498)(1,426)
Net income (loss):(48,470)(43,862)3,384(30,298)
Other undisclosed net income (loss) attributable to parent27,1607,130(42,999)2,320
Net loss available to common stockholders, diluted:(21,310)(36,732)(39,615)(27,978)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(48,470)(43,862)3,384(30,298)
Other comprehensive loss (36,736)(39,614)(27,978)
Comprehensive loss:(48,470)(80,598)(36,230)(58,276)
Other undisclosed comprehensive income, net of tax, attributable to parent27,163   
Comprehensive loss, net of tax, attributable to parent:(21,307)(80,598)(36,230)(58,276)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: